logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

China’s Humanwell Gains US FDA Approval for Potassium Chloride Powder

Nov 26, 2018

Life Science

Report: Exploring Fundamental Drivers Behind CSW Industrials, DMC Global, National HealthCare, Milestone Scientific, EnSync, and Trio-Tech International — New Horizons, Emerging Trends, and Upcoming Developments

Nov 26, 2018

Life Science

Shanghai Cell Therapy Closes $40 Million C1 Round for Cancer Drugs

Nov 26, 2018

Life Science

Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate®)

Nov 26, 2018

Life Science

With New HQ, Ipsen to Rapidly Expand North American Presence

Nov 23, 2018

Life Science

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

Nov 23, 2018

Life Science

Merck announces innovative MS treatment MAVENCLAD® (Cladribine Tablets) selected for rapid uptake by the Accelerated Access Collaborative,默克公司多发性硬化症治疗药物Mavenclad®(克拉屈滨片)获AAC认可

Merck announces innovative MS treatment MAVENCLAD® (Cladribine Tablets) selected for rapid uptake by the Accelerated Access Collaborative

Nov 23, 2018

Life Science

Milestone Scientific Inc. (NYSE America: MLSS)

Milestone Scientific Announces Recent Presentations Featuring The Wand® STA

Nov 23, 2018

Life Science

Novartis gets European approval for sight therapy Luxturna

Nov 22, 2018

Life Science

China’s iKang Healthcare to Introduce AI Technology, Founder Says

Nov 22, 2018

Life Science

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai

Nov 22, 2018

Life Science

Sinclair Pharma Announces Acquisition of the Company by Huadong Medicine Co., Ltd

Nov 20, 2018

Life Science

Alma, a Sisram Medical Company, Announces the Opening of a Direct Operation in Israel Following the Acquisition of Its Israeli Distributor

Nov 20, 2018

Life Science

Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis

Nov 20, 2018

Life Science

CASI Pharma to Build Manufacturing Plant in Wuxi, China

Nov 20, 2018

Life Science

Immunocore and Genentech Dig into Immuno-Oncology in Solid Tumors With Expanded Research Deal

Nov 19, 2018

Life Science

China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection

Nov 19, 2018

Life Science

Alphamab Oncology of Suzhou Closes $100 Million A Round for Cancer Drugs

Nov 19, 2018

Life Science

  • ‹‹ Previous
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada